• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氨蝶呤和依那西普对幼年特发性关节炎患者 B 细胞群的不同影响。

Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritis.

机构信息

Hannover Medical School, Hannover, Germany.

出版信息

Arthritis Rheumatol. 2014 Sep;66(9):2590-600. doi: 10.1002/art.38736.

DOI:10.1002/art.38736
PMID:24909567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4288311/
Abstract

OBJECTIVE

B cells have been shown to play an important role in the pathogenesis of rheumatoid arthritis and juvenile idiopathic arthritis (JIA). Current treatments include the disease-modifying antirheumatic drugs methotrexate (MTX) and tumor necrosis factor α inhibition with etanercept. This study was undertaken to determine how these drugs influence the B cell compartment in patients with JIA.

METHODS

B cell subpopulations and follicular helper T (Tfh) cells in the peripheral blood of JIA patients were investigated by multicolor flow cytometry. Serum immunoglobulin and BAFF levels were determined by enzyme-linked immunosorbent assay.

RESULTS

There was a significant decrease in transitional B cells and significantly lower serum immunoglobulin levels in patients receiving MTX than in untreated patients and those receiving etanercept. In contrast, etanercept treatment had no effect on most of the B cell subpopulations, but resulted in significantly lower BAFF levels and increased numbers of Tfh cells. Thus, our findings indicate an unexpected and previously unknown direct effect of low-dose MTX on B cells, whereas etanercept had a more indirect influence.

CONCLUSION

Our results contribute to a better understanding of the potency of MTX in autoantibody-mediated autoimmune disease and present a possible mechanism of prevention of the development of drug-induced antibodies to biologic agents. The finding that MTX and etanercept affect the B cell compartment differently supports the notion that combination therapy with etanercept and MTX is more effective than monotherapy.

摘要

目的

已证实 B 细胞在类风湿关节炎和幼年特发性关节炎(JIA)的发病机制中发挥重要作用。目前的治疗方法包括甲氨蝶呤(MTX)等疾病修饰抗风湿药物和依那西普等肿瘤坏死因子α抑制剂。本研究旨在确定这些药物如何影响 JIA 患者的 B 细胞群。

方法

通过多色流式细胞术检测 JIA 患者外周血中的 B 细胞亚群和滤泡辅助 T(Tfh)细胞。通过酶联免疫吸附试验测定血清免疫球蛋白和 BAFF 水平。

结果

与未治疗患者和接受依那西普治疗的患者相比,接受 MTX 治疗的患者过渡性 B 细胞显著减少,血清免疫球蛋白水平显著降低。相比之下,依那西普治疗对大多数 B 细胞亚群没有影响,但导致 BAFF 水平降低和 Tfh 细胞数量增加。因此,我们的研究结果表明,低剂量 MTX 对 B 细胞具有意想不到的、以前未知的直接作用,而依那西普的影响则更为间接。

结论

我们的研究结果有助于更好地理解 MTX 在自身抗体介导的自身免疫性疾病中的作用,并提出了预防生物制剂药物诱导抗体产生的可能机制。MTX 和依那西普对 B 细胞群的影响不同,这一发现支持依那西普和 MTX 联合治疗比单一治疗更有效的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/3664b20c5294/art0066-2590-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/212913e14a2f/art0066-2590-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/07fcf22d9d9a/art0066-2590-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/cd9731a12853/art0066-2590-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/1baf2581a8fb/art0066-2590-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/3664b20c5294/art0066-2590-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/212913e14a2f/art0066-2590-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/07fcf22d9d9a/art0066-2590-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/cd9731a12853/art0066-2590-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/1baf2581a8fb/art0066-2590-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fda8/4288311/3664b20c5294/art0066-2590-f5.jpg

相似文献

1
Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritis.甲氨蝶呤和依那西普对幼年特发性关节炎患者 B 细胞群的不同影响。
Arthritis Rheumatol. 2014 Sep;66(9):2590-600. doi: 10.1002/art.38736.
2
Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.依那西普在特定类型幼年特发性关节炎儿童中的长期安全性和有效性。
Arthritis Rheum. 2009 Sep;60(9):2794-804. doi: 10.1002/art.24777.
3
Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study.接受依那西普治疗的幼年特发性关节炎患者的医学相关感染增加:来自英国儿科和青少年风湿病学会依那西普队列研究的结果。
Arthritis Rheumatol. 2015 Sep;67(9):2487-94. doi: 10.1002/art.39197.
4
Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.在接受或未接受抗TNF治疗的传统改善病情抗风湿药治疗的幼年特发性关节炎患者中,接种23价肺炎球菌多糖疫苗后的短期和长期免疫原性及安全性。
Vaccine. 2015 Jan 29;33(5):604-9. doi: 10.1016/j.vaccine.2014.12.030. Epub 2014 Dec 29.
5
Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.在接受甲氨蝶呤和依那西普治疗的幼年特发性关节炎患儿中进行麻疹、腮腺炎和风疹复种疫苗的疗效研究。
Rheumatology (Oxford). 2009 Feb;48(2):144-8. doi: 10.1093/rheumatology/ken436. Epub 2008 Dec 11.
6
Etanercept in systemic juvenile idiopathic arthritis.依那西普治疗全身型幼年特发性关节炎
Clin Exp Rheumatol. 2002 Sep-Oct;20(5):723-6.
7
A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study.依那西普与甲氨蝶呤联合治疗难治性幼年特发性关节炎的一项初步研究。
Ann Rheum Dis. 2001 Apr;60(4):410-2. doi: 10.1136/ard.60.4.410.
8
Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.采用早期积极治疗的新发多关节型幼年特发性关节炎患儿队列中的临床非活动性疾病:达到时间、总持续时间及预测因素
J Rheumatol. 2014 Jun;41(6):1163-70. doi: 10.3899/jrheum.131503. Epub 2014 May 1.
9
Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.与仅使用依那西普治疗相比,依那西普与甲氨蝶呤联合治疗幼年特发性关节炎(JIA)患者的安全性和有效性:来自德国JIA注册研究的初步数据。
Ann Rheum Dis. 2009 Apr;68(4):519-25. doi: 10.1136/ard.2007.087593. Epub 2008 Apr 15.
10
Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.依那西普:关于其在类风湿关节炎、银屑病关节炎和幼年类风湿关节炎中应用的最新综述。
Drugs. 2002;62(17):2493-537. doi: 10.2165/00003495-200262170-00013.

引用本文的文献

1
Immunometabolism in heart failure.心力衰竭中的免疫代谢
Nat Rev Cardiol. 2025 Jun 22. doi: 10.1038/s41569-025-01165-8.
2
Calycosin synergizes with methotrexate in the treatment of Sjögren's disease by targeting BATF in T follicular helper cells.毛蕊异黄酮通过靶向滤泡辅助性T细胞中的BATF,与甲氨蝶呤协同治疗干燥综合征。
Acta Pharmacol Sin. 2025 Apr 3. doi: 10.1038/s41401-025-01536-4.
3
Integrating single cell expression quantitative trait loci summary statistics to understand complex trait risk genes.整合单细胞表达数量性状基因座汇总统计数据,以了解复杂性状风险基因。

本文引用的文献

1
Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases.药物水平、抗药物抗体与抗 TNF-α 生物制剂在风湿性疾病中的临床疗效。
Clin Rheumatol. 2013 Oct;32(10):1429-35. doi: 10.1007/s10067-013-2336-x. Epub 2013 Jul 26.
2
B cell activating factor-dependent expression of vascular endothelial growth factor in MH7A human synoviocytes stimulated with tumor necrosis factor-α.B 细胞激活因子依赖的血管内皮生长因子在肿瘤坏死因子-α刺激的 MH7A 人滑膜细胞中的表达。
Int Immunopharmacol. 2013 Sep;17(1):142-7. doi: 10.1016/j.intimp.2013.04.026. Epub 2013 May 14.
3
The good, the bad and the ugly - TFH cells in human health and disease.
Nat Commun. 2024 May 20;15(1):4260. doi: 10.1038/s41467-024-48143-1.
4
Children with extended oligoarticular and polyarticular juvenile idiopathic arthritis have alterations in B and T follicular cell subsets in peripheral blood and a cytokine profile sustaining B cell activation.患有扩展性寡关节炎和多关节炎型幼年特发性关节炎的儿童在外周血中存在 B 和 T 滤泡细胞亚群的改变以及支持 B 细胞激活的细胞因子谱。
RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2022-002901.
5
Effect of DMARDs on the immunogenicity of vaccines.DMARDs 对疫苗免疫原性的影响。
Nat Rev Rheumatol. 2023 Sep;19(9):560-575. doi: 10.1038/s41584-023-00992-8. Epub 2023 Jul 12.
6
Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients.重复剂量强化 COVID-19 疫苗接种可改善原发性无应答或低应答者和 B 细胞缺陷性风湿病患者的体液免疫。
J Autoimmun. 2023 Feb;135:102996. doi: 10.1016/j.jaut.2023.102996. Epub 2023 Jan 9.
7
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study).在 COVID-19 疫苗加强针后 2 周暂停低剂量甲氨蝶呤治疗对炎症性疾病免疫抑制成人疫苗应答的影响:一项多中心随机对照试验和嵌套机制亚研究方案(疫苗应答开/关甲氨蝶呤(VROOM)研究)。
BMJ Open. 2022 May 3;12(5):e062599. doi: 10.1136/bmjopen-2022-062599.
8
Juvenile idiopathic arthritis.幼年特发性关节炎
Nat Rev Dis Primers. 2022 Jan 27;8(1):5. doi: 10.1038/s41572-021-00332-8.
9
BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors.BAFF 可预测接受 TNF 抑制剂治疗的老年类风湿关节炎患者的免疫原性。
Sci Rep. 2021 Jun 2;11(1):11632. doi: 10.1038/s41598-021-91177-4.
10
Effects of Chemotherapy Agents on Circulating Leukocyte Populations: Potential Implications for the Success of CAR-T Cell Therapies.化疗药物对循环白细胞群体的影响:对CAR-T细胞疗法成功的潜在影响。
Cancers (Basel). 2021 May 6;13(9):2225. doi: 10.3390/cancers13092225.
良莠不齐——滤泡辅助性 T 细胞在人类健康与疾病中的作用
Nat Rev Immunol. 2013 Jun;13(6):412-26. doi: 10.1038/nri3447. Epub 2013 May 17.
4
Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging Study.贝利尤单抗治疗类风湿关节炎患者的疗效和安全性:一项 II 期、随机、双盲、安慰剂对照、剂量范围研究。
J Rheumatol. 2013 May;40(5):579-89. doi: 10.3899/jrheum.120886. Epub 2013 Apr 1.
5
Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.关节内甲氨蝶呤联合脂纳米乳液:对抗原诱导关节炎的抗炎作用。
Int J Nanomedicine. 2013;8:443-9. doi: 10.2147/IJN.S29392. Epub 2013 Feb 14.
6
Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.利妥昔单抗:挽救危及生命的并发症或难治性自身免疫性疾病的治疗方法:单中心经验。
Rheumatol Int. 2013 Jun;33(6):1495-504. doi: 10.1007/s00296-012-2587-x. Epub 2012 Dec 14.
7
Developing connections amongst key cytokines and dysregulated germinal centers in autoimmunity.在自身免疫中发展关键细胞因子和失调生发中心之间的联系。
Curr Opin Immunol. 2012 Dec;24(6):658-64. doi: 10.1016/j.coi.2012.10.003. Epub 2012 Nov 1.
8
Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis.辅助性 T 细胞 1(Th1)和辅助性 T 细胞 17(Th17)亚群在系统性幼年特发性关节炎患者外周血中富集。
Rheumatology (Oxford). 2012 Oct;51(10):1881-6. doi: 10.1093/rheumatology/kes162. Epub 2012 Jul 5.
9
Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action.类风湿关节炎滑膜中腺苷受体的表达:甲氨蝶呤作用的基础。
Arthritis Res Ther. 2012 Jun 8;14(3):R138. doi: 10.1186/ar3871.
10
Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis.类风湿关节炎患者循环滤泡辅助性T细胞频率增加。
Clin Dev Immunol. 2012;2012:827480. doi: 10.1155/2012/827480. Epub 2012 May 10.